A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations

Published:2019-11 Issue: Volume:121 Page:224-235
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

George Sally L.,Izquierdo Elisa,Campbell James,Koutroumanidou Eleni,Proszek Paula,Jamal Sabri,Hughes Deborah,Yuan Lina,Marshall Lynley V.,Carceller Fernando,Chisholm Julia C.,Vaidya Sucheta,Mandeville Henry,Angelini Paola,Wasti Ajla,Bexelius Tomas,Thway Khin,Gatz Susanne A.,Clarke Matthew,Al-Lazikani Bissan,Barone Giuseppe,Anderson John,Tweddle Deborah A.,Gonzalez David^ORCID,Walker Brian A.,Barton Jack,Depani Sarita,Eze Jessica,Ahmed Saira W.,Moreno Lucas^ORCID,Pearson Andrew,Shipley Janet,Jones Chris,Hargrave Darren,Jacques Thomas S.,Hubank Michael,Chesler Louis^ORCID

Funder

Christopher's Smile

National Institute of Health Research (NIHR) Royal Marsden Biomedical Research Centre

Children With Cancer UK

Cancer Research UK

Abbie's Fund

Rosetree Trust

KiCa Fund

King Baudouin Foundation

Panel development

Brain Tumour Charity

CWC UK

GOSH Children's Charity

CRUK

Olivia Hodson Cancer

NIHR

GOSH

Oak Foundation

CCLG

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference42 articles.

1. Precision medicine ethics: selected issues and developments in next-generation sequencing, clinical oncology, and ethics;Fiore;Curr Opin Oncol,2016

2. A collaborative approach to enabling stratified cancer medicine in the UK;Tuff-Lacey;Drug Discov Today,2015

3. The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer;Middleton;Ann Oncol,2015

4. An overview of the NCI precision medicine trials-NCI MATCH and MPACT;Do;Chin Clin Oncol,2015

5. FDA approval summary: olaparib monotherapy in patients with deleterious germline BRCA-mutated advanced ovarian cancer treated with three or more lines of chemotherapy;Kim;Clin Cancer Res,2015

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision cancer medicine platform trials: Concepts and design of AcSé-ESMART;European Journal of Cancer;2024-09

2. Precision oncology across the ages: Impact on children, adolescents, and young adults;Cancer Cell;2024-09

3. Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression;Acta Neuropathologica Communications;2024-08-10

4. Evolution of the Innovative Therapies for Children With Cancer Consortium Trial Portfolio for Drug Development for Children With Cancer;Journal of Clinical Oncology;2024-07-20

5. Advancing presurgical non-invasive molecular subgroup prediction in medulloblastoma using artificial intelligence and MRI signatures;Cancer Cell;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3